If you have any problems related to the accessibility of any content (or if you want to request that a specific publication be accessible), please contact (email@example.com). We will work to respond to each request in as timely a manner as possible.
Synthesis of Macrocyclic Polyamines and their Cu, Fe, Mn and Zn Complexes Targeting HIV (AIDS).
AdvisorBell, Thomas W.
StatisticsView Usage Statistics
Macrocyclic polyamines cyclotriazadisulfonamide (CADA) and bicyclam AMD3100 act as entry inhibitors against HIV by different mechanisms. The manganese complex of pyridine-fused macrocyclic polyamine (M40401) has been found to reduce HIV-1 induced apoptosis of astroglial cells. Based on these findings, seventeen new compounds were designed and synthesized, including five macrocyclic polyamines (<bold>SH07</bold>, <bold>SH09</bold>, <bold>SH25</bold>, <bold>SH26</bold>, <bold>SH28</bold>) and their copper (<bold>SH34</bold>, <bold>SH37</bold>), iron (<bold>SH35</bold>, <bold>SH38</bold>), manganese (<bold>SH06</bold>, <bold>SH08</bold>, <bold>SH15</bold>, <bold>SH16</bold>, <bold>SH21</bold>, <bold>SH23</bold>) and zinc (<bold>SH36</bold>, <bold>SH39</bold>) complexes. Moreover, synthesis of twelve previously reported compounds of biological interest is reported including macrocyclic polyamines and their copper, iron, manganese and zinc complexes (<bold>SH04</bold>, <bold>SH05</bold>, <bold>SH14</bold>, <bold>SH19</bold>, <bold>SH20</bold>, <bold>SH22</bold>, <bold>SH26</bold>, <bold>SH28</bold>, <bold>SH29</bold>, <bold>SH31</bold>, <bold>SH32</bold> and <bold>SH33</bold>). All the newly reported macrocyclic polyamines are characterized by <super>1</super>H and <super>13</super>C NMR spectroscopy, and ESI mass spectrometry. Additionally, microanalysis (<bold>SH07</bold> and <bold>SH09</bold>) and HRMS (<bold>SH26</bold>) data were obtained. All metal complexes are characterized by ESI MS and microanalysis. Testing of some of these compounds for inhibition of HIV replication in cell cultures uncovered five leads, SH06 (IC50 = 0.41 ± 0.06 μg/mL, CC50 = 20 μg/mL), SH15 (IC50 = 0.50 ± 0.16 μg/mL, CC50 = >100 μg/mL), SH16 (IC50 = 1.23 ± 0.50 μg/mL, CC50 = 51 μg/mL), SH34 (IC50 = 0.86 ± 0.35 μg/mL, CC50 = >100 μg/mL) and SH36 (IC50 = 0.49 ± 0.22 μg/mL, CC50 = >100 μg/mL). Testing of some more analogs SH28, SH37, SH38 and SH39 against HIV is in progress.
Showing items related by title, author, creator and subject.
Expanding the scope of organizational behavior management: Relational frame theory and the experimental analysis of complex human behavior Hayes, Steven C.; Bunting, Kara; Herbst, Scott; Bond, Frank W.; Barnes-Holmes, Dermot (2006)Behavior analysis in general and applied behavior analysis in particular requires a well developed, empirically Supported, and useful approach to human language and cognition in order to fulfill its mission of providing a ...
.Shani-Kadmiel, Shahar; Tsesarsky, Michael; Louie, John N.; Gvirtzman, Zohar (8/1/2012)The Dead Sea Transform (DST) is the source for some of the largest earthquakes in the eastern Mediterranean. The seismic hazard presented by the DST threatens the Israeli, Palestinian, and Jordanian populations alike. ...
Structural and Photophysical Properties of Visible- and Near-IR-Emitting Tris Lanthanide(III) Complexes Formed with the Enantiomers of N,N'-Bis(1-phenylethyl)-2,6-pyridinedicarboxamide Hua, KimNgan T.; Xu, Jide; Quiroz, Eliseo E.; Lopez, Sabrina; Ingram, Andrew J.; Johnson, Victoria Anne; Tisch, Angela R.; de Bettencourt-Dias, Ana; Straus, Daniel A.; Muller, Gilles (2012)The enantiomers of N,N'-bis(1-phenylethyl)-2,6-pyridinedicarboxamide (L), namely, (R,R)-1, and (S,S)-1, react with LnIII ions to give stable [LnL3]3+ complexes in an anhyd. acetonitrile soln. and in the solid state, as ...